Soliton with ticker code (SOLY) have now 3 analysts in total covering the stock. The consensus rating is ‘Buy’. The range between the high target price and low target price is between 22 and 12 calculating the mean target price we have 16. Now with the previous closing price of 8.37 this is indicating there is a potential upside of 91.2%. The 50 day MA is 8.4 and the 200 day MA is 8.22. The market cap for the company is $177m. Company Website: http://www.soliton.com
The potential market cap would be $338m based on the market concensus.
Soliton, a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers product for the removal of tattoos. It also develops product for cellulite reduction, fibrotic scar treatment, and other indications. The company was founded in 2012 and is based in Houston, Texas.
